Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a side effect of
bisphosphonate therapy, primarily diagnosed in patients with cancer and metastatic bone …

Background: Invasive dental treatment in patients exposed to antiresorptive and
antiangiogenic drugs can cause medication-related osteonecrosis of the jaw (MRONJ) …

Introduction Scientific debate outlines tooth extraction as a potential trigger for the onset of
bisphosphonate-related osteonecrosis of the jaw (BRONJ). Therefore, the aim of this study …

PURPOSE: Osteoradionecrosis (ORN) is a nonhealing wound of the bone that is difficult to
manage. Combined treatment with pentoxifylline and vitamin E reduces radiation-induced …

Root amputation, extraction of a single tooth, bone loss or severe tooth mobility, and an
unclosed wound were significantly associated with increased risk of developing medication …

PURPOSE: Osteonecrosis of the jaw has been reported in patients receiving high doses of
intravenous nitrogen-containing bisphosphonates (N-BPs) because of malignant disease …

Oral Diseases (2011) 17, 194–199 Objectives: Bisphosphonate‐associated osteonecrosis of
the jaw (BP‐ONJ) is a side effect in patients being treated with bisphosphonates. The …

Bisphosphonate-associated osteonecrosis of the jaw (BP-ONJ) is one of the most often seen
side effects in patients treated with bisphosphonates, presenting clinically as a non-healing …

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a challenging complication
resulting from the long-term application of bisphosphonates. In most cases, BRONJ occurs …

Bisphosphonate related osteonecrosis of the jaw (BRONJ) is rare but potentially severe, and
the etiopathology and risk factors are poorly defined. To date, it has not been possible to …